Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : HCWB save search
HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights
Published: 2024-04-01 (Crawled : 20:00) - globenewswire.com
HCWB | $1.62 -0.61% 870
|
|
| O: 0.0%
H: 7.04%
C: 0.61%
business year financial results
HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlights
Published: 2023-11-14 (Crawled : 12:00) - globenewswire.com
HCWB | $1.62 -0.61% 870
|
|
| O: -6.38%
H: 0.76%
C: -12.12%
business financial results
Investigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting
Published: 2023-11-08 (Crawled : 12:30) - globenewswire.com
HCWB | $1.62 -0.61% 870
|
|
| O: 6.25%
H: 11.76%
C: -7.65%
hcw9218 readout meeting trial
Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meeting
Published: 2023-11-01 (Crawled : 12:00) - globenewswire.com
HCWB | $1.62 -0.61% 870
|
|
| O: -4.76%
H: 0.0%
C: -0.63%
hcw9218 presentation readout tumors cancer meeting study
HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023
Published: 2023-09-06 (Crawled : 12:00) - globenewswire.com
HCWB | $1.62 -0.61% 870
|
|
| O: -0.51%
H: 0.52%
C: -2.58%
conference global
HCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
Published: 2023-08-11 (Crawled : 11:00) - globenewswire.com
HCWB | $1.62 -0.61% 870
|
|
| O: -1.67%
H: 5.68%
C: 5.68%
business financial results
HCW Biologics is Granted Third Fundamental Patent: U.S. Patent for Methods of Treating Age-Related Disorders
Published: 2023-06-14 (Crawled : 12:00) - globenewswire.com
HCWB | $1.62 -0.61% 870
|
|
| O: 5.47%
H: 0.47%
C: -1.65%
patent granted
HCW Biologics Reports First Quarter 2023 Financial Results And Recent Business Highlights
Published: 2023-05-09 (Crawled : 11:00) - globenewswire.com
HCWB | $1.62 -0.61% 870
|
|
| O: -0.7%
H: 5.67%
C: 5.67%
business financial results
HCW Biologics Secures $26.25 Million Non-Dilutive Financing With Asset-Backed Development Loan
Published: 2023-04-27 (Crawled : 12:00) - globenewswire.com
HCWB | $1.62 -0.61% 870
|
|
| O: 6.39%
H: 0.26%
C: -2.73%
HCW Biologics Poster Presentation at AACR Annual Meeting 2023
Published: 2023-04-13 (Crawled : 13:00) - biospace.com/
HCWB | $1.62 -0.61% 870
|
|
| O: 0.0%
H: 3.45%
C: -1.38%
presentation meeting
A Novel Immunotherapeutic Approach to Treating Aging-Associated Diseases
Published: 2023-04-03 (Crawled : 12:20) - globenewswire.com
HCWB | $1.62 -0.61% 870
|
|
| O: -3.43%
H: 0.52%
C: 0.52%
HCW Biologics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights
Published: 2023-03-28 (Crawled : 22:00) - globenewswire.com
HCWB | $1.62 -0.61% 870
|
|
| O: 14.18%
H: 0.09%
C: -3.86%
business year financial results
HCW Biologics Enters CRADA with National Cancer InstituteNCI Activated as Clinical Site for Phase 1b/2 Clinical Trial to Evaluate HCW9218 in Advanced Pancreatic Cancer
Published: 2022-12-08 (Crawled : 14:00) - biospace.com/
HCWB | $1.62 -0.61% 870
|
|
| O: 4.82%
H: 0.0%
C: -1.48%
hcw9218 trial cancer pancreatic phase 2b
HCW Biologics Enters CRADA with National Cancer Institute
Published: 2022-12-08 (Crawled : 13:00) - globenewswire.com
HCWB | $1.62 -0.61% 870
|
|
| O: 4.82%
H: 0.0%
C: -1.48%
cancer
HCW Biologics to Participate in H.C. Wainwright Annual Global Life Sciences Conference May 23 – 25, 2022
Published: 2022-05-23 (Crawled : 12:00) - globenewswire.com
HCWB | $1.62 -0.61% 870
|
|
| O: 3.1%
H: 5.52%
C: 0.58%
sciences
HCW Biologics Reports First Quarter 2022 Financial Results and Recent Business Highlights
Published: 2022-05-13 (Crawled : 12:00) - biospace.com/
HCWB | $1.62 -0.61% 870
|
|
| O: 4.52%
H: 14.9%
C: -5.29%
results
HCW Biologics to Showcase Two Novel Groups of Fusion Molecules Created with Proprietary and Versatile TOBI™ Platform At the 105th Annual Meeting of the American Association of Immunologists
Published: 2022-05-05 (Crawled : 13:00) - biospace.com/
HCWB | $1.62 -0.61% 870
|
|
| O: -1.77%
H: 4.27%
C: -0.45%
platform
HCW Biologics’ CEO Hing C. Wong, Ph.D., to be Featured Speaker at the Third Annual International Conference on Cell and Experimental Biology 2022
Published: 2022-04-19 (Crawled : 12:00) - globenewswire.com
HCWB | $1.62 -0.61% 870
|
|
| O: 5.64%
H: 0.0%
C: -3.91%
ceo conference international
HCW Biologics Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights for 2021
Published: 2022-03-28 (Crawled : 20:00) - biospace.com/
HCWB | $1.62 -0.61% 870
|
|
| O: -3.1%
H: 2.4%
C: -3.6%
results
Masonic Cancer Center at the University of Minnesota Receives FDA Clearance to Proceed with Phase 1 Clinical Trial in Solid Tumors for HCW9218
Published: 2022-01-24 (Crawled : 13:00) - biospace.com/
HCWB | $1.62 -0.61% 870
|
|
| O: 5.45%
H: 0.47%
C: 0.0%
hcw9218 fda clearance solid tumors trial fda clearance phase 1 cancer
Gainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.64 166.67% 18M
|
AGBA | $2.61 108.8% 41M
|
Finance
CZOO | $9.32 86.77% 18M
|
EDBL | News | $6.7 78.19% 1.7M
|
OPRT | News | $3.37 49.78% 8.9M
|
Finance
MTC | $2.14 37.18% 4.9M
|
Technology Services
VNRX | $0.8 33.33% 2.9M
|
Health Technology
MLEC | $1.79 27.86% 2.6M
|
n/a
PALI | $6.29 27.59% 22M
|
Manufacturing
MCRB | $0.7902 26.51% 6.9M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.